Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Friedman

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Digital Health|July 25, 2022
The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York CityMia T Minen, Neil A Busis, Steven Friedman, et al.
Gynecologic Oncology|July 12, 2025
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 14, 2022
Neurologists' Evaluations of Experience and Effectiveness of Teleneurology EncountersSujata P Thawani, Mia T Minen, Rebecca S Stainman, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2Chu-Biao Xue, Anlai Wang, David Meloni, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|August 25, 2023
A Comparison of Patients' and Neurologists' Assessments of their Teleneurology Encounter: A Cross-Sectional AnalysisSujata P Thawani, Mia T Minen, Scott N Grossman, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 ActivityChu-Biao Xue, Lihua Chen, Ganfeng Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 AntagonistChu-Biao Xue, Hao Feng, Ganfeng Cao, et al.
Journal of the American Academy of Dermatology|July 19, 2025
Satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: Risk factors and the prognostic significanceVartan Pahalyants, Neil K Jairath, Derek E Maas, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Digital Health|July 25, 2022
The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York CityMia T Minen, Neil A Busis, Steven Friedman, et al.
Gynecologic Oncology|July 12, 2025
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 14, 2022
Neurologists' Evaluations of Experience and Effectiveness of Teleneurology EncountersSujata P Thawani, Mia T Minen, Rebecca S Stainman, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2Chu-Biao Xue, Anlai Wang, David Meloni, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|August 25, 2023
A Comparison of Patients' and Neurologists' Assessments of their Teleneurology Encounter: A Cross-Sectional AnalysisSujata P Thawani, Mia T Minen, Scott N Grossman, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 ActivityChu-Biao Xue, Lihua Chen, Ganfeng Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 AntagonistChu-Biao Xue, Hao Feng, Ganfeng Cao, et al.
Journal of the American Academy of Dermatology|July 19, 2025
Satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: Risk factors and the prognostic significanceVartan Pahalyants, Neil K Jairath, Derek E Maas, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 7